memantine hydrochloride (LYN-057) / Lyndra - LARVOL DELTA

[VIRTUAL] Ultra Long-Acting Oral Therapies for Alzheimer's: Proof of Principle (AAIC 2020) - "Lyndra's novel drug delivery technology achieved controlled release of memantine and donepezil resulting in consistent pharmacokinetics (PK) exposure over 7 days. The ability to deliver one or more oral drugs over one week with a single oral capsule has the potential to improve compliance, quality of life, and care of people with Alzheimer's disease."

Alzheimer's Disease • CNS Disorders • Gastrointestinal Disorder • Pain